Cytokinetics, Inc. (CYTK)
60.69
-0.91
(-1.48%)
USD |
NASDAQ |
Apr 28, 16:00
60.66
-0.02
(-0.04%)
After-Hours: 20:00
Cytokinetics Research and Development Expense (TTM) : 405.90M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 9.492B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| AtriCure, Inc. | 90.17M |
| Johnson & Johnson | 14.99B |
| Edgewise Therapeutics, Inc. | 149.30M |